Virtus ETF Advisers’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,487
| Closed | -$80K | – | 359 |
|
|
2020
Q3 | $80K | Sell |
1,487
-203
| -12% | -$10.9K | 0.04% | 321 |
|
|
2020
Q2 | $425K | Sell |
1,690
-688
| -29% | -$173K | 0.2% | 177 |
|
|
2020
Q1 | $374K | Sell |
2,378
-347
| -13% | -$54.6K | 0.15% | 202 |
|
|
2019
Q4 | $446K | Buy |
2,725
+1,496
| +122% | +$245K | 0.07% | 222 |
|
|
2019
Q3 | $180K | Sell |
1,229
-69
| -5% | -$10.1K | 0.04% | 264 |
|
|
2019
Q2 | $270K | Sell |
1,298
-56
| -4% | -$11.6K | 0.06% | 260 |
|
|
2019
Q1 | $282K | Sell |
1,354
-184
| -12% | -$38.3K | 0.6% | 63 |
|
|
2018
Q4 | $269K | Sell |
1,538
-1,043
| -40% | -$182K | 0.05% | 149 |
|
|
2018
Q3 | $585K | Sell |
2,581
-1,849
| -42% | -$419K | 0.06% | 102 |
|
|
2018
Q2 | $671K | Buy |
4,430
+1,014
| +30% | +$154K | 0.59% | 114 |
|
|
2018
Q1 | $625K | Buy |
3,416
+1,835
| +116% | +$336K | 0.54% | 102 |
|
|
2017
Q4 | $337K | Sell |
1,581
-283
| -15% | -$60.3K | 0.42% | 107 |
|
|
2017
Q3 | $400K | Buy |
1,864
+171
| +10% | +$36.7K | 0.05% | 112 |
|
|
2017
Q2 | $320K | Buy |
1,693
+608
| +56% | +$115K | 0.05% | 108 |
|
|
2017
Q1 | $268K | Buy |
1,085
+104
| +11% | +$25.7K | 0.05% | 154 |
|
|
2016
Q4 | $249K | Buy |
+981
| New | +$249K | 0.07% | 144 |
|